Amit Shah meets Paresh Mesta’s family; skips Kumta rally due to fever

Mangaluru, Apr 18: The residents of Thokkottu welcomed a COVID-19 patient who was cured and discharged from hospital with a standing ovation. 

The man remained in quarantine after returning from Tablighi Jammat religious gathering at Nizamuddin in Delhi. He was tested positive for COVID-19 on April 4 and was shifted to Wenlock Hospital for treatment.

After he was tested positive, a complete lockdown was announced within a 200-metre radius of the apartment where he was residing at Thokkottu.

The cured patient will have to remain quarantined at home for the next 14 days.

He has thanked the doctors, nurses and paramedical staff of Wenlock Hospital who took care of him in the hospital. 

In the meantime, 12 COVID-19 patients out of 13 have been cured and discharged from the hospital in Dakshina Kannada district.

More than 500 flights are expected to be operated in the fourth phase of Vande Bharat Mission, the “paid evacuation” mission of the government of India during covid-19 crisis.

This includes both Air India and private carriers who are ramping up their operations in a big way. 

Air India will be operating 170 flights till 15th of July to and from 17 countries, including Australia, Bahrain, Bangladesh, Canada, Germany, Japan, Kuwait, Malaysia, Oman, Saudi Arabia, Qatar and Philippines.

Private airlines such as IndiGo and GoAir will have significant participation in the fourth phase of Vande Bharat Mission. 

The Civil Aviation Ministry said that among others, Indigo will operate 238 flights from Qatar and 219 flights from Kuwait. GoAir will operate 41 flights from Kuwait. Phase Four will particularly focus on countries where there still are a large number of Indians who have registered to return.

Meanwhile, a record five lakh stranded Indians have returned safely to India under the Mission till now. The operations commenced on 7th May and in less than two months, nearly five lakh four thousand stranded Indians from 137 countries have returned to their homes.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.